A 7-year Follow up of All Subjects Incuded in Protocol 31GB0106

NCT01146275 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Galderma R&D